13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q4 2025 · Filed January 23, 2026 · Accession 0001193125-26-020931
Total Value
$835.0M
Positions
5
Other Managers
1
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $499.3M | 59.80% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $123.8M | 14.83% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $100.7M | 12.06% |
| 4 | RAPT THERAPEUTICS INC | 75382E109 | 2,794,000 | $94.6M | 11.33% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $16.6M | 1.98% |